Amerisourcebergen Corp
LSE:0HF3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Amerisourcebergen Corp
Revenue
Amerisourcebergen Corp
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Amerisourcebergen Corp
LSE:0HF3
|
Revenue
$325.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Cardinal Health Inc
NYSE:CAH
|
Revenue
$244.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Revenue
$13.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Revenue
$6.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Mckesson Corp
NYSE:MCK
|
Revenue
$398B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Cencora Inc
NYSE:COR
|
Revenue
$325.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
Amerisourcebergen Corp
Glance View
AmerisourceBergen Corp., a titan in the realm of pharmaceutical services, orchestrates the flow of medications across a vast and intricate network. Rooted in Chesterbrook, Pennsylvania, the company has cemented its place as a critical link in the healthcare supply chain. Serving as a bridge between pharmaceutical manufacturers and a wide array of healthcare providers like hospitals, clinics, and pharmacies, AmerisourceBergen leverages its expansive distribution infrastructure to ensure that medications and health products reach their destinations efficiently and reliably. The company's operations are bolstered by its strategic partnerships and collaboration with a plethora of healthcare entities, enabling it to integrate seamlessly into the delivery systems that support patient care. At its core, AmerisourceBergen turns the complexity of healthcare logistics into a streamlined process, generating revenue primarily through the distribution of pharmaceuticals. It purchases medications from manufacturers, sells them at a markup to healthcare providers, and in doing so, balances a robust supply chain fueled by efficiency and scale. But the story doesn't end at distribution; the company has expanded its reach through value-added services such as consulting, data analytics, and patient support services that further solidify its role in the healthcare ecosystem. Whether navigating regulatory environments or advising on patient care strategies, AmerisourceBergen positions itself as not just a distributor, but a partner in health. Through this dual approach of distribution and strategic services, the company ensures it remains vital to both manufacturers and healthcare providers, creating a sustainable business model that capitalizes on both volume and innovation.
See Also
What is Amerisourcebergen Corp's Revenue?
Revenue
325.8B
USD
Based on the financial report for Dec 31, 2025, Amerisourcebergen Corp's Revenue amounts to 325.8B USD.
What is Amerisourcebergen Corp's Revenue growth rate?
Revenue CAGR 10Y
9%
Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Amerisourcebergen Corp have been 10% over the past three years , 11% over the past five years , and 9% over the past ten years .